scholarly article | Q13442814 |
P2093 | author name string | Haiyong Wang | |
Lisong Teng | |||
Mengjie Wu | |||
Haohao Wang | |||
Zhongqi Li | |||
Zhenzhen Xu | |||
Xiongfei Yu | |||
Xiaoxia Jiang | |||
P2860 | cites work | Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal Cancers | Q26781362 |
Global cancer statistics, 2012 | Q27860501 | ||
Mammalian MAP kinase signalling cascades | Q28204140 | ||
Stat3 as an oncogene | Q29614606 | ||
Tumor metastasis: molecular insights and evolving paradigms | Q29615908 | ||
WEGO: a web tool for plotting GO annotations | Q29616658 | ||
Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors | Q33941380 | ||
STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer | Q34306802 | ||
The MAPK pathway across different malignancies: a new perspective | Q34459097 | ||
Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention | Q34595904 | ||
STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. | Q53594652 | ||
Suppression of cancer relapse and metastasis by inhibiting cancer stemness | Q35090120 | ||
Strategies and Approaches of Targeting STAT3 for Cancer Treatment. | Q35884979 | ||
Structure-activity analysis of niclosamide reveals potential role for cytoplasmic pH in control of mammalian target of rapamycin complex 1 (mTORC1) signaling | Q36006981 | ||
The challenge of targeting metastasis | Q36322825 | ||
KEGG as a reference resource for gene and protein annotation | Q36434599 | ||
Discovery of O-Alkylamino-Tethered Niclosamide Derivatives as Potent and Orally Bioavailable Anticancer Agents | Q36641981 | ||
Constitutive activation of STAT3 in breast cancer cells: A review | Q36711689 | ||
Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications | Q36749049 | ||
Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma. | Q37345331 | ||
STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer | Q37491122 | ||
Pathological roles of MAPK signaling pathways in human diseases | Q37676393 | ||
Targeting MAPK pathway in melanoma therapy | Q38098888 | ||
A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer | Q38170840 | ||
Compromised MAPK signaling in human diseases: an update | Q38359194 | ||
Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells | Q38360859 | ||
c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014). | Q38492604 | ||
A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors | Q38503202 | ||
Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells | Q38558752 | ||
The prognostic value of pSTAT3 in gastric cancer: a meta-analysis | Q38559001 | ||
Suppression of the Growth and Invasion of Human Head and Neck Squamous Cell Carcinomas via Regulating STAT3 Signaling and the miR-21/β-catenin Axis with HJC0152. | Q38718723 | ||
Targeting metastasis | Q38786658 | ||
Cancer treatment and survivorship statistics, 2016. | Q38859236 | ||
Cancer Statistics, 2017. | Q39038674 | ||
IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer | Q39587868 | ||
Cancer statistics in China, 2015. | Q40064386 | ||
Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line. | Q40064435 | ||
Niclosamide As a Potential Nonsteroidal Therapy for Endometriosis That Preserves Reproductive Function in an Experimental Mouse Model. | Q41634189 | ||
Role of MAPKs in platinum-induced neuronal apoptosis. | Q46018598 | ||
FH535 Inhibits Proliferation and Motility of Colon Cancer Cells by Targeting Wnt/β-catenin Signaling Pathway | Q47135534 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 11 | |
P304 | page(s) | 6857-6867 | |
P577 | publication date | 2018-01-01 | |
P1433 | published in | Cancer Management and Research | Q5031417 |
P1476 | title | HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer | |
P478 | volume | 10 |
Q64087577 | A novel STAT3 inhibitor, HJC0152, exerts potent antitumor activity in glioblastoma |
Q92094288 | Dysregulated miRNA in a cancer-prone environment: A study of gastric non-neoplastic mucosa |
Q89542508 | HJC0152 suppresses human non-small-cell lung cancer by inhibiting STAT3 and modulating metabolism |
Q92626717 | Upregulation of family with sequence similarity 83 member D expression enhances cell proliferation and motility via activation of Wnt/β-catenin signaling and predicts poor prognosis in gastric cancer |
Search more.